Article successfully added.

CyFlow™ HLA-G FITC

CyFlow™ HLA-G FITC
Antibody: Yes
Antigen: HLA-G
Application: Flow cytometry
Clonality: monoclonal
Clone: 01G
Emission Maximum: 518 nm
Excitation Maximum: 490 to 495 nm
Field of Interest: MHC
Format/Fluorochrome: FITC
Isotype: IgG1
Laser: Blue
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: CB784162

For Research Use Only

$235.00 USD*

Price excludes any applicable taxes plus shipping costs

Description Documentation TDS & SDS
Description
Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 mL... more
Close menu
CyFlow™ HLA-G FITC
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenHLA-B27 transgenic mice were immunized with H-2 identical mouse cells transfected with and expressing genes encoding HLA-G and human β2-microglobulin
UsageThe reagent is designed for Flow Cytometry analysis. Suggested working usage is 5·µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Real LM, Cabrera T, Collado A, Jimenez P, Garcia A, Ruiz-Cabello F, Garrido F: Expression of HLA G in human tumors is not a frequent event. Int J Cancer. 1999 May 17; 81(4):512‑8. < PMID: 10225437 > | Real LM, Cabrera T, Canton J, Oliva R, Ruiz-Cabello F, Garrido F: Looking for HLA‑G expression in human tumours. J Reprod Immunol. 1999 Jul; 43(2):263‑73. < PMID: 10479062 > | Polakova K, Russ G: Expression of the non‑classical HLA‑G antigen in tumor cell lines is extremely restricted. Neoplasma. 2000; 47(6):342‑8. < PMID: 11263857 > | Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE: Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA‑E, F and G in Maternal‑Placental Immune Recognitions. J Immunol. 2003; 171:1376. < PMID: 12874228 > | Polakova K, Bandzuchova E, Hofmeister V, Weiss EH, Hutter H, Russ G: Binding analysis of HLA‑G specific antibodies to hematopoietic cells isolated from leukemia patients. Neoplasma. 2003; 50(5):331‑8. < PMID: 14628085 > | Polakova K, Krcova M, Kuba D, Russ G: Analysis of HLA‑G expression in malignant hematopoetic cells from leukemia patients. Leuk Res. 2003 Jul; 27(7):643‑8. < PMID: 12681364 > | Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M: Expression of the immune‑tolerogenic major histocompatibility molecule HLA‑G in multiple sclerosis: implications for CNS immunity. Brain. 2005 Nov; 128(11):2689‑2704. < PMID: 16123145 >

TDS & SDS
Close menu

Technical Data Sheet

Safety Data Sheet